Cytori Therapeutics (CYTX) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts CYTX Hot Sheet
Price: $0.21 --0%
Financial Fact:
Total product revenues: 1.47M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total product revenues: 1.47M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Cytori Therapeutics (NASDAQ: CYTX) reported Q2 EPS of ($0.19), $0.02 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $2.23 million.
For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
